A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1999
10/07/1999	CA2324476A1 Treatment and prevention of vascular disease
10/07/1999	CA2324445A1 Blk genes, gene products and uses thereof in apoptosis
10/07/1999	CA2324444A1 P53-regulated genes
10/07/1999	CA2324441A1 Materials and methods relating to a novel retrovirus
10/07/1999	CA2324440A1 Directed antisense libraries
10/07/1999	CA2324421A1 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999	CA2321960A1 Treatment and diagnosis of staphylococcal infections
10/07/1999	CA2290363A1 Method of inhibiting immune system destruction of transplanted viable cells
10/06/1999	EP0947583A2 DNA fragments activated in expression of melanoma inhibiting protein (MIA)
10/06/1999	EP0946880A1 Method for diagnosis and therapy of hodgkin lymphomas
10/06/1999	EP0946755A1 Methods and compositions for polypeptide engineering
10/06/1999	EP0946751A1 Atherothrombotic disorders: mutation in the factor xiii gene
10/06/1999	EP0946744A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
10/06/1999	EP0946742A1 Chimeric adenoviral vectors
10/06/1999	EP0946741A1 Method for producing recombinant virus
10/06/1999	EP0946740A1 Novel constructs and vectors for the targeted and inducible expression of genes
10/06/1999	EP0946733A1 Hsv/aav hybrid amplicon vectors
10/06/1999	EP0946724A2 POLYPEPTIDES OF THE "BASIC-HELIX-LOOP-HELIX" bHLH FAMILY, CORRESPONDING NUCLEIC ACID SEQUENCES
10/06/1999	EP0946721A1 Human growth gene and short stature gene region
10/06/1999	EP0946719A1 Guanine exchange factor of rho gtpase and nucleic acid encoding it
10/06/1999	EP0946718A1 Nucleic acid constructs and uses thereof for direct nucleic acid incorporation into cells
10/06/1999	EP0946713A1 Method for in vitro preconditioning of myoblasts before transplantation
10/06/1999	EP0946201A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
10/06/1999	EP0946200A1 Immunization of infants
10/06/1999	EP0946199A1 TGF beta 1-RESPONSIVE CELLS FROM BONE MARROW
10/06/1999	EP0946192A1 Uses of thioredoxin
10/06/1999	EP0946189A1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
10/06/1999	EP0946148A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
10/06/1999	CN1230998A Three component chimeric antisense oligonucleotides
10/06/1999	CN1230989A Embryonic or stem-like cell lines produced by cross species nuclear transplantation
10/06/1999	CN1230893A Assembly-deficient herpesvirus vaccine
10/06/1999	CN1230595A Construction of deletion wither inhibitor gene virus and its application in the gene therapy of tumor
10/05/1999	US5962667 Pharmaco-gene delivery in human breast cancer cells
10/05/1999	US5962666 Polynucleotide or its complement which codes for enzyme involved in bacterial protein synthesis; for diagnosis and treatment of chlamydia infections such as urogenital disorders and vision defects; bactericides
10/05/1999	US5962653 Methods of obtaining antiviral proteins and antiviral peptides from Nostoc ellipsosporum
10/05/1999	US5962652 Antibodies to protein, FAF1
10/05/1999	US5962429 Complexes of adenovirus with cationic molecules
10/05/1999	US5962427 Targeting, transferring dna into mammalian repair cells
10/05/1999	US5962426 Hybrid
10/05/1999	US5962425 Hydridizing oligonucleotide
10/05/1999	US5962424 Inducing selectin expression using ionizing radiation
10/05/1999	US5962411 Human growth hormone variants and methods of administering same
10/05/1999	US5962318 Cytotoxic T lymphocyte-mediated immunotherapy
10/05/1999	US5962316 Cell-cycle regulatory proteins, and uses related thereto
10/05/1999	US5962313 Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
10/05/1999	US5962312 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders
10/05/1999	US5962311 A method of targeting attachment of a short-shafted recombinant adenovirus to a cell so as to effect entry of the short-shafted recombinant adenovirus into the cell.
10/05/1999	US5962310 Vehicle for delivery of particles to a sample
10/05/1999	US5962303 The invention relates to polynucleotides and polypeptides of bacterial ?topoisomerase iii.?
10/05/1999	US5962295 This invention relates to newly identified polynucleotides and polypeptides, and their production and uses, as well as their variants, agonists and antagonists, and their uses.
10/05/1999	US5962268 DNA encoding an immune cell cytokine
10/05/1999	US5962259 Response regulator polynucleotides
10/05/1999	US5962235 Antibody or fragment specific for intracellular enzyme; for immunoassay diagnosis of cancer
10/05/1999	US5962230 Diagnosis and treatment of glaucoma
10/05/1999	CA2161962C Adenovirus vectors for gene therapy
10/01/1999	CA2249043A1 Novel compounds
09/1999
09/30/1999	WO1999049316A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer
09/30/1999	WO1999049067A1 Nucleic acid transfer vectors, compositions containing same and uses
09/30/1999	WO1999049065A1 Antisense modulation of human mdm2 expression
09/30/1999	WO1999049054A1 Diagnostics and vaccines for mycobacterial infections of animals and humans
09/30/1999	WO1999049041A1 Drm, a secreted protein with cell growth inhibiting activity, and related methods and compositions
09/30/1999	WO1999049034A1 Breast cancer antigen
09/30/1999	WO1999049030A1 Compounds related to pap-1
09/30/1999	WO1999049027A1 Methods for prevention and treatment of cancer
09/30/1999	WO1999049025A2 Human vault rna
09/30/1999	WO1999049018A1 Glycosyl sulfotransferase-3
09/30/1999	WO1999049014A1 Localization and propagation of neural and neuronal progenitor cells
09/30/1999	WO1999048916A2 Hypoxia-inducible human genes, proteins, and uses thereof
09/30/1999	WO1999048537A1 Use of scatter factor to enhance angiogenesis
09/30/1999	WO1999048514A1 Methods and materials for treating inflammatory diseases
09/30/1999	WO1999040945A3 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
09/30/1999	WO1999039741A3 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
09/30/1999	WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders
09/30/1999	WO1999037777A3 Differentiation-associated sequences and methods of use therefor
09/30/1999	WO1999037325A3 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
09/30/1999	WO1999036562A9 Nucleotide expression systems with reduced immunogenicity for use in gene therapy
09/30/1999	WO1999036560A3 Viral vectors encoding neurofilament light proteins and their use
09/30/1999	WO1999035277A3 Recombinant, active caspases and uses thereof
09/30/1999	WO1999035266A3 Human urotensin ii
09/30/1999	WO1999035245A9 Methods for preparing and using immortalized human neuroendocrine cells
09/30/1999	WO1999035242A9 Media for neuroendocrine cells
09/30/1999	WO1999032149A9 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER)
09/30/1999	WO1999031261A9 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS
09/30/1999	WO1999013898A9 EC-3, AN INHIBITOR OF α4β1 AND α4β7 INTEGRINS
09/30/1999	DE19913864A1 DNA fragments useful for increasing p53 activity in a cell and reducing susceptibility to UV-induced hyperproliferative diseases
09/30/1999	CA2326053A1 Use of scatter factor to enhance angiogenesis
09/30/1999	CA2324345A1 Human vault rna
09/30/1999	CA2323831A1 Nucleic acid transfer vectors, compositions containing same and uses
09/30/1999	CA2323782A1 Methods for prevention and treatment of cancer
09/30/1999	CA2323501A1 Compounds related to pap-1
09/30/1999	CA2322843A1 Hypoxia-inducible human genes, proteins, and uses thereof
09/30/1999	CA2322779A1 Glycosyl sulfotransferase-3
09/30/1999	CA2322773A1 Antisense modulation of human mdm2 expression
09/29/1999	EP0945512A2 Novel serine proteases
09/29/1999	EP0945507A1 Tumor specific expression controll region and its use
09/29/1999	EP0945506A1 Novel peptide, novel dna, and novel antibody
09/29/1999	EP0945138A1 Transfection particles
09/29/1999	EP0944724A1 USE OF A VECTOR EXPRESSING DNA POLYMERASE $g(b) AS MEDICINE
09/29/1999	EP0944722A2 Pituitary-tumor-transforming-genes, and related products
09/29/1999	EP0944721A1 Adipocyte-specific differentiation-related protein

1 ... 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 ... 870